The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic and surgical treatment in renal cell carcinoma: Does timing matter?
 
Konstantin Egon Seitzer
Travel, Accommodations, Expenses - Ipsen
 
Christopher Darr
Honoraria - Bayer; Ipsen; Janssen
Consulting or Advisory Role - Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Thomas Hilser
Honoraria - IPSEN,
 
Andres Jan Schrader
Honoraria - Astellas Oncology; Bayer; Janssen-Cilag
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Janssen-Cilag
 
Linda Huberth
No Relationships to Disclose
 
Anne Mausbach
No Relationships to Disclose
 
Martin Janssen
No Relationships to Disclose
 
Laura-Maria Krabbe
Honoraria - Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; IPSEN,; Janssen-Cilag; Medac; Merck; MSD; Novartis; Onkowissen; Pfizer; Recordati; Roche; Sanofi
Consulting or Advisory Role - Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; IPSEN,; Janssen-Cilag; Medac; Merck; MSD; Novartis; Onkowissen; Pfizer; Recordati; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; IPSEN,; Janssen-Cilag; Medac; Merck; MSD; Novartis; Onkowissen; Pfizer; Recordati; Roche; Sanofi
 
Barbara Heitplatz
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen
 
Martin Boegemann
Employment - Janssen; Janssen
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; Janssen-Cilag
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Onkowissen; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Serono; Pfizer